Also, regarding adjuvant short-term chemotherapy regimens, a slightly greater proportion of respondents changed their preference to anthracycline-free regimens versus an anthracycline-containing regimen (Table 2 ), although this difference did not reach statistical significance ( P = 0.435).
← all excerpts
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.
1
0.4350
0.4350